Saroglitazar is a dual peroxisome proliferator-activated receptor alpha/gamma (PPARα/γ) agonist used for the management of type 2 diabetes mellitus and dyslipidemia, particularly to reduce triglyceride… Read more








![Chemical structure of 1-[4-(Methylthio)phenyl]-1,4-pentanedione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F189501-33-5-1-4-Methylthiophenyl-14-pentanedione.png&w=3840&q=75)









Saroglitazar is a dual peroxisome proliferator-activated receptor alpha/gamma (PPARα/γ) agonist used for the management of type 2 diabetes mellitus and dyslipidemia, particularly to reduce triglyceride and cholesterol levels in patients inadequately controlled by statin therapy. This category contains a comprehensive collection of high-quality reference standards for Saroglitazar, including related impurities, synthesis by-products, potential metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these materials for precise impurity profiling, method validation, and rigorous quality control protocols to ensure drug safety and efficacy. By incorporating these analytical standards, researchers and quality assurance professionals can accurately identify and quantify unknown substances within drug batches, supporting compliance with regulatory standards throughout the development and manufacturing lifecycle of this therapeutic agent.